Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E N, Moore D H, Meli S, Gasparini G
Department of Pathology, University of California, San Francisco 94143-0102.
J Natl Cancer Inst. 1992 Dec 16;84(24):1875-87. doi: 10.1093/jnci/84.24.1875.
Axillary lymph node status has been the most important prognostic factor in operable breast carcinoma, but it does not fully account for the varied disease outcome. More accurate prognostic indicators would help in selection of patients at high risk for disease recurrence and death who are candidates for systemic adjuvant therapy. Our recent findings indicated that microvessel density (count or grade) in invasive breast carcinoma (a measure of tumor angiogenesis) is associated with metastasis and thus may be a prognostic indicator.
This study was designed to further define the relationship of microvessel density with overall and relapse-free survival and with other reported prognostic indicators in breast carcinoma.
In a prospective, blinded study of 165 consecutive patients, the microvessels within primary invasive breast carcinoma were highlighted by immunocytochemical staining to detect factor VIII-related antigen. Using light microscopy, we counted microvessels per 200x field in the most active areas of neovascularization and graded microvessel density. These findings were correlated, by univariate and multivariate analyses, with overall and relapse-free survival, axillary node status, and other prognostic indicators (median follow-up, 51 months).
There was a highly significant (P < or = .001) association of microvessel density with overall survival and relapse-free survival in all patients, including node-negative and node-positive subsets. All patients with breast carcinomas having more than 100 microvessels per 200x field experienced tumor recurrence within 33 months of diagnosis, compared with less than 5% of the patients with breast carcinoma having 33 or fewer microvessels per 200x field. Moreover, microvessel density was the only statistically significant predictor of overall survival among node-negative women (P < .001). Only microvessel density (P < .001) and histologic grade (P = .04) showed statistically significant correlations with relapse-free survival in the node-negative subset.
Microvessel density in the area of the most intense neovascularization in invasive breast carcinoma is an independent and highly significant prognostic indicator for overall and relapse-free survival in patients with early-stage breast carcinoma (I or II by International Union Against Cancer criteria).
Such an indicator would be useful in selection of those node-negative patients with breast carcinoma who are at high risk for having occult metastasis at presentation. These patients could then be given systemic adjuvant therapy.
腋窝淋巴结状态一直是可手术乳腺癌最重要的预后因素,但它并不能完全解释疾病转归的差异。更准确的预后指标将有助于筛选出疾病复发和死亡风险高、适合接受全身辅助治疗的患者。我们最近的研究结果表明,浸润性乳腺癌中的微血管密度(计数或分级,一种肿瘤血管生成的指标)与转移相关,因此可能是一种预后指标。
本研究旨在进一步明确微血管密度与乳腺癌患者总生存和无复发生存以及其他已报道的预后指标之间的关系。
在一项对165例连续患者的前瞻性、盲法研究中,通过免疫细胞化学染色突出原发性浸润性乳腺癌内的微血管,以检测因子VIII相关抗原。使用光学显微镜,我们在新生血管最活跃的区域每200倍视野计数微血管并对微血管密度进行分级。通过单因素和多因素分析,将这些结果与总生存和无复发生存、腋窝淋巴结状态及其他预后指标(中位随访时间51个月)进行关联。
在所有患者中,包括淋巴结阴性和阳性亚组,微血管密度与总生存和无复发生存均存在高度显著相关性(P≤0.001)。每200倍视野有超过100个微血管的所有乳腺癌患者在诊断后33个月内出现肿瘤复发,相比之下,每200倍视野有33个或更少微血管的乳腺癌患者中这一比例不到5%。此外,微血管密度是淋巴结阴性女性总生存的唯一具有统计学意义的预测指标(P<0.001)。在淋巴结阴性亚组中,只有微血管密度(P<0.001)和组织学分级(P = 0.04)与无复发生存显示出统计学显著相关性。
浸润性乳腺癌新生血管最密集区域的微血管密度是早期乳腺癌(按国际抗癌联盟标准为I期或II期)患者总生存和无复发生存的独立且高度显著的预后指标。
这样一个指标将有助于筛选出那些初诊时存在隐匿转移高风险的淋巴结阴性乳腺癌患者。然后可给予这些患者全身辅助治疗。